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TheMixed Lineage Leukemia (Mll) gene is a ho-
molog of Drosophila Trithorax commonly re-
arranged in infant leukemia.Comprehensiveanal-
ysis of the role of Mll in hematopoiesis in fetal
and adult knockout mice has been prevented
by the lethality of Mll/ mice. We have estab-
lished a conditional deletion model that allows
us to study adult hematopoiesis in the absence
of Mll. In this study, Mll/ embryos survive to
E16.5 and have reduced numbers of HSCs.
The quiescent fraction of these HSCs is greatly
reduced, and they are unable to compete with
wild-type cells in transplantation assays. Mice
with Mll expression conditionally deleted in
the hematopoietic system have grossly normal
hematopoiesis in bone marrow, thymus, and
spleen. However, transplanted Mll-deficient
bone marrow cells are highly compromised in
their ability to competitively reconstitute irradi-
ated recipients. These results suggest a critical
role forMll in regulating stem cell self-renewal.
INTRODUCTION
The Mixed Lineage Leukemia (MLL) gene is a homolog of
the Drosophila Trithorax (Trx) gene that was first discov-
ered through its role in acute leukemia. Translocations
that result in the in-frame fusion ofMll to over 40 different
partner genes are the primary genetic abnormalities found
in infant acute lymphocytic leukemia (ALL) and acutemye-
loid leukemia (AML) (Hess, 2004). The Mll gene codes for
a large protein with several domains, including two regions
of homology to TRX protein—a conserved histonemethyl-
transferase region known as the SET domain and Plant
Homeodomain (PHD) zinc fingers, that are involved in pro-
tein-protein interactions (Fair etal., 2001;Milneet al., 2002).
The SET domain has been shown to be active in chromatin
remodeling complexes that facilitate histone H3 Lys4
methylation at the promoters of Hox genes, resulting in
gene activation (Dou et al., 2006; Milne et al., 2002, 2005).
Mll mouse knockout models have confirmed the view
that Mll is a regulator of multiple Hox genes. Mice hetero-338 Cell Stem Cell 1, 338–345, September 2007 ª2007 Elseviezygous forMll show homeotic transformations of the axial
skeleton characteristic of Hox misexpression (Yu et al.,
1995). Cells from Mll-deficient embryoid bodies and fetal
livers show reduced expression of several Hox genes
(Ernst et al., 2004a; Yagi et al., 1998; Yu et al., 1995).
This deregulation of Hox gene expression is also thought
to contribute to the hematopoietic abnormalities seen in
Mll-deficient embryos. The yolk sac and fetal livers of em-
bryos lacking Mll are reduced in cellularity and have re-
duced colony-forming capacity (Hess et al., 1997; Yagi
et al., 1998). Cells from the aorta-gonad-mesonephros
(AGM) region ofMll-deficient embryos are unable to repop-
ulate the bone marrow of irradiated mice, unlike Mll wild-
type (WT) controls (Ernst et al., 2004b). Chimera experi-
ments with Mll-deficient cells also showed a profound
block in hematopoiesis, with no contribution from Mll-
deficient embryonic stem (ES) cells to any of the hemato-
poietic lineages seen in adult chimaeras.
As yet, with the exception of the chimera experiments,
no investigation has been made into the role of Mll in
postnatal hematopoiesis. In this study, we describe a new
mouse model that utilizes a conditional allele ofMll where
exons 8 and 9 of the gene can be excised. The removal of
exons 8 and 9 leads to complete loss of the MLL protein,
and mice homozygous for this deletion (Mll/ or Mll KO
mice) die between embryonic day (E) 12.5 and 16.5. Anal-
ysis of fetal liver fromMll KO embryos shows defects in the
hematopoietic stem and progenitor pool, including reduc-
tions in long-term hematopoietic stem cell (LT-HSC) and
short-term hematopoietic stem cell (ST-HSC) number
and a decrease in the quiescent HSC fraction. Adult Mll
conditional knockout mice (Mll cKO) have no apparent
abnormalities in mature hematopoietic cells in the bone
marrow, spleen, and thymus. However, Mll cKO bone
marrow cells produce reduced numbers of colony-
forming units (CFUs) in methylcellulose cultures. In addi-
tion, bone marrow cells from Mll cKO mice show a
dramatic loss in their ability to compete in hematopoietic
reconstitution assays.
RESULTS
Fetal Liver Hematopoiesis Is Disrupted at an Early
Stage of Development in the Absence of Mll
Homozygous deletion of Mll results in embryonic lethality
(Ayton et al., 2001; Yagi et al., 1998; Yu et al., 1995). Inr Inc.
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Mll, we have established novel Mll KO and cKO mouse
lines (Supplemental Experimental Procedures and Fig-
ure S1 in the Supplemental Data available with this article
online). Mll KO mice die during embryogenesis between
E12.5 and E16.5. No MLL protein could be detected by
immunoblotting of protein lysates made from Mll KO fetal
liver cells (Figure 1A). It has previously been shown that an
absence of Mll leads to disrupted hematopoiesis during
fetal development (Ernst et al., 2004b; Hess et al., 1997;
Yagi et al., 1998). The availability of embryos at E13.5–
E14.5 has allowed us to perform a more comprehensive
study of hematopoietic defects in the absence of Mll. Al-
though total fetal liver cellularity is reduced 2-fold in Mll
KO compared toMll+/+ (Mll WT) embryos, a 5-fold expan-
sion in fetal liver size is seen in both between E13.5 and
E14.5 (Figure 1B). This expansion appears to be due pri-
marily to increased numbers of Ter119+ erythroid cells
(Figure 1C).Mll KO fetal liver cells also have defects in my-
eloid CFU assays, consistent with previous models (Yagi
et al., 1998) (Figure S2).
Having seen reductions in cell number and CFU pro-
duction in Mll KO fetal livers, we then decided to analyze
the HSC population for similar defects. To assess this,
we have performed flow cytometric analyses to examine
the HSC pool in E13.5 fetal livers. It has been shown that
the different HSC populations in the fetal liver can be de-
fined by flow cytometry using a combination of lineage
markers and antibodies to c-kit, Sca1, and CD38
(Randall et al., 1996). LineageSca1+c-kithi (LSK) fetal
liver cells that express high levels of CD38 are highly en-
riched for LT-HSCs, whereas those that express low
levels of CD38 are enriched for ST-HSCs (Randall
et al., 1996). InMll KO fetal livers, we observe a 4-fold re-
duction in the number of LT-HSCs compared to Mll WT
and a 3-fold reduction in the number of ST-HSC cells
(Figures 1D–1F). The percentage of LT-HSCs is also re-
duced in Mll KO fetal livers (data not shown). To assess
whether this reduction in HSC populations is due to al-
tered cell-cycle status, we analyzed E13.5 c-kithiSca1+
fetal liver cells with the proliferation marker Ki67 and
the DNA stain 7AAD (Nygren et al., 2006). As shown in
Figures 2A and 2B, the percentage of c-kithiSca1+ cells
in G0 is significantly reduced in Mll KO fetal liver. This
shows a major loss in the number of quiescent HSCs
present in Mll KO fetal liver.
A reduction in the quiescent HSC pool has been sug-
gested to result in eventual HSC exhaustion and impaired
self-renewal capacity (Hock et al., 2004; Ohta et al., 2002).
To assess the function of HSCs present in Mll KO fetal
livers, we performed competitive repopulation assays
with fetal liver cells from E14.5 Mll KO and Mll WT em-
bryos. Analysis of blood taken from recipients at 4 weeks
posttransplantation shows thatMll WT cells can reconsti-
tute short-term hematopoiesis efficiently, as measured by
the percentage of Ly5.2+ cells present in the periphery. In
contrast, Mll KO cells are unable to give rise to any short-
term reconstitution (Figure 2C). At 4 months posttrans-
plantation,Mll KO cells are absent from all the hematopoi-Cell Stetic organs analyzed (Figures 2C and 2D), including the
bone marrow HSC compartment (data not shown), sug-
gesting that Mll-deficient fetal liver stem cells are unable
to give rise to long-term hematopoiesis. These results
show that Mll is necessary for the expansion of fetal liver
HSCs and to maintain a normal cell-cycle profile in the
HSC pool. In the absence of Mll, these cells presumably
exhaust and are unable to propagate either short- or
long-term hematopoieis.
Homeostatic Hematopoiesis in Adult Mice
Is Unaffected by the Absence of Mll
The dramatic phenotype seen in Mll KO fetal livers sug-
gested thatMll would also have an important role in post-
natal hematopoiesis. To test this hypothesis, we have
established a conditional knockout model, using the Vav
Cre transgene, where expression of Mll is ablated only in
the hematopoietic system. Mll cKO mice were born live
and were of similar weight to MllFlox/+ littermates (data
not shown). Analysis of tissues from MllFlox/ VavCre mice
(Mll cKOmice) confirmed that the floxed allele was recom-
bined efficiently, resulting in a loss ofMll from hematopoi-
etic organs and bone marrow HSCs (Figures S3A–S3C).
To determine the effect ofMll deficiency on adult hemato-
poiesis, we have analyzed the major blood cell lineages in
Mll cKO mice by flow cytometry. MllFlox/+ mice were used
as controls, because these were comparable to wild-type
mice in similar assays (data not shown). There is no differ-
ence in the total cell number of the spleen and thymus be-
tween Mll cKO and MllFlox/+ littermates (data not shown).
No significant differences are apparent between Mll cKO
and MllFlox/+ mice in any of the major blood cell popula-
tions (Figures 3A–3C). This surprising result suggests
that Mll is not required to maintain normal steady-state
hematopoiesis postnatally or for the differentiation of
mature hematopoietic cells.
The unexpected phenotype seen in the hematopoietic
system of Mll cKO mice led us to examine the phenotype
of Mll cKO fetal liver. Due to expression of the Vav Cre
transgene, Mll was recombined in E13.5 fetal livers
(Figure S3D). Analysis ofMll cKO fetal livers shows no sig-
nificant difference in the number of ST-HSCs or LT-HSCs
in Mll cKO fetal livers compared to control fetal livers
(Figures S4A and S4B), although a 2-fold reduction in
CFU number is seen inMll cKO CFU assays (Figure S4C).
The difference in phenotype betweenMll cKO andMll KO
fetal livers suggests chimeric expression of the Cre at ear-
lier stages of fetal development.
There was no phenotype inMll cKO fetal liver stem cells
as analyzed by flow cytometry. In contrast, a functional
defect was seen when the cells were cultured in methyl-
cellulose. Similarly, in adult Mll cKO bone marrow, there
is no reduction in LSK stem cells as analyzed by flow
cytometry (Figure 3D). To assess whether adult Mll cKO
progenitor cells are functional, CFU assays were per-
formedwithMll cKO bonemarrow cells. Significant reduc-
tions inCFUnumber are seenwhen the cells are cultured in
both Pre-B and myeloid conditions (Figures 3E and 3F). In
myeloid conditions, the proportions of CFU-granulocyte,em Cell 1, 338–345, September 2007 ª2007 Elsevier Inc. 339
Cell Stem Cell
Mll and Hematopoietic Stem Cell Self-RenewalFigure 1. Hematopoietic Abnormalities in Mll KO Fetal Livers
(A) Expression of MLL protein in Mll WT, HET, and KO embryos. Whole-cell lysates made from fetal liver cells were run alongside a positive control
(K562 cell lysate). Anti-MLLN- andC-terminal monoclonal antibodieswere used to detect theMLL-N terminus (300 kDa) andMLL-C terminus (180
kDa) fragments. The membrane was probed with an antibody against Hsp-90 as a loading control.
(B) Expansion in cell number between E13.5 and E14.5 inMll WT, HET, and KO fetal livers. Single-cell suspensions were prepared from individual fetal
liversandviable countsperformed.P valueswerecalculatedbyusingone-wayANOVA,withTukeysmultiple comparison test. Error bars showthemean
and the standard error of the mean (SEM). ***p% 0.001, **p% 0.01, and *p% 0.05. All samples were compared toMll WT. For all samples n = 5–11.
(C)Theproportionof Ter119+erythroidcells inMllKOE13.5andE14.5 fetal livers is equivalent toMllWT. Representativeplots showingTer119stainingof
E13.5 and E14.5Mll KO andMll WT fetal liver cells overlaid over an isotype control.
(D) Identifying LT-HSCs and ST-HSCs. Cells were stainedwith Lin markers, c-kit, Sca-1, CD38, 7AAD, and Streptavidin-PerCP. Lineage-negative cells
were removed by magnetic sorting, dead cells were gated out, and LinSca1+ cells were analyzed for the expression of c-kit and CD38.
(E) Number of LT-HSCs present inWT, HET, and KO E13.5 fetal livers. LT-HSCs were defined as LinSca1+c-kithiCD38hi.
(F) Number of ST-HSCs present inWT, HET, and KO E13.5 fetal livers. ST-HSCs were defined as LinSca1+c-kithiCD38lo.340 Cell Stem Cell 1, 338–345, September 2007 ª2007 Elsevier Inc.
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Mll and Hematopoietic Stem Cell Self-RenewalFigure 2. Altered Cell-Cycle Profile and Repopulation Capacity in Mll KO HSCs
(A) Representative plots showing analysis of cell cycle in HSCs. E13.5 fetal liver cells were stained with c-kit and Sca1. The expression of the
proliferation marker Ki67 was analyzed against DNA content (7AAD) in c-kithiSca1+ cells.
(B) Cell-cycle profiles ofWT and KO E13.5 fetal liver HSCs (c-kithiSca1+). A significant reduction in the percentage of HSCs in G0 is seen in KO HSCs
(n = 3) compared to WT (n = 8). Error bars show the mean and the SEM. Unpaired t tests were used to calculate p values.
(C) Failure of Mll KO fetal liver cells to reconstitute lethally irradiated recipients. c-kit+Ter119 cells were sorted from frozen E14.5 fetal liver cell
suspensions (Ly5.2+). 4 3 104 sorted cells were transplanted into irradiated recipients with a radioprotective dose of 2 3 105 Ly5.1+ wild-type
bone marrow cells. All host mice were C57Bl/6J Ly5.1+. The table shows the number of recipients successfully reconstituted with either WT or
KO fetal liver cells. Short-term reconstitution was defined as 4 weeks, long-term reconstitution as 4 months.
(D) The figure displays representative dot plots showing the percentage of Ly5.2+ cells present in the hematopoietic organs of irradiated recipients
4 months posttransplantation.erythroid, macrophage, megakaryocyte (CFU-GEMM)
and burst-forming unit erythroid (BFU-E) are decreased
in comparison to control cultures, suggesting a defect in
an early myeloid progenitor (Figure S4D). This suggests
that, in the absence of Mll, there are defects in both lym-
phoid and myeloid progenitors.Cell SBone Marrow Cells from Mll cKO Mice
Have a Profound Reconstitution Defect
The reduction in CFU formation from Mll cKO progenitor
cells led us to question whether Mll cKO stem cells also
have functional defects. We have performed competitive
repopulation assays to assess whether bone marrowtem Cell 1, 338–345, September 2007 ª2007 Elsevier Inc. 341
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poiesis in Mll cKO Mice
(A–C) Flow cytometric analyses of hematopoi-
etic cells in Mll cKO mice. For all experiments,
MllFlox/+ (Flox/+) mice were used as controls.
The graphs show the mean and SEM
(n = 3–5). Eight-week-old females were used
for all analyses with the exception of T cells in
the thymus, where equal numbers of males
and females were used from each genotype.
(A) Myeloid cells from the bone marrow (BM)
and the spleen (S) were analyzed for Gr1 and
Mac1. Granulocytes (Gr) were defined as
Gr1hiMac1+, monocytes (Mo) were defined as
Gr1loMac1+. (B) B cells were analyzed from
the bone marrow, spleen, and lymph node
(LN) for the presence of B220. (C) T cells from
the spleen and thymus (T) were analyzed with
CD4 and CD8.
(D) Percentage of LSK HSCs in the bone mar-
row of Mll cKO mice.
(E) Pre BCFU counts forMll Flox/+ andMll cKO
bone marrow cells. 5.53 104 cells were plated
in methylcellulose, and CFUs were counted af-
ter 7 days. Unpaired t tests were used to calcu-
late p values.
(F) Myeloid CFU counts for Mll Flox/+ and Mll
cKO bone marrow cells after 10 days in culture
in methylcellulose. 2.7 3 104 cells were plated
in methylcellulose.stem cells lacking Mll are able to compete with Mll wild-
type stem cells. Bonemarrow cells fromMll cKO,MllFlox/,
andMllFlox/+mice were transplanted into lethally irradiated
recipients with C57BL/6J Ly5.1+ competitor bone marrow
cells in a 1:1 ratio or 10:1 ratio.Mll cKO bone marrow cells
give very low levels of short-term reconstitution when
transplanted at either a 1:1 or 10:1 ratio (Figure 4A). At 4
months posttransplantation, Mll cKO cells give less
than 1% long-term reconstitution when transplanted at
a 1:1 ratio with WT cells and 2% ± 2% reconstitution
when transplanted at a 10:1 ratio (Figures 4B and 4C).
The reconstitution defect seen in Mll cKO cells is not
due to an inability of the bone marrow cells to home to he-
matopoietic niches, as homing of these cells to the bone
marrow of lethally irradiated recipients is equivalent to
Mll WT cells (Figures S5A and S5B). These results demon-
strate that, although Mll-deficient hematopoietic stem
cells are able to contribute to steady-state hematopoiesis,
their ability to proliferate and self-renew is severely com-
promised when they are placed in competition with WT
cells.
DISCUSSION
In this study, we have shown thatMll is necessary for fetal
liver hematopoiesis but that it is dispensable for the devel-
opment of mature lineages in postnatal hematopoiesis. In342 Cell Stem Cell 1, 338–345, September 2007 ª2007 Elsevieour model, deletion of exons 8 and 9 ofMll leads to a total
abolition of MLL protein, demonstrating that this model
represents a complete MLL knockout. Previous studies
withMll knockout models have shown defects in hemato-
poiesis in the yolk sac, aorta-gonad-mesonephros (AGM),
and fetal liver in the absence ofMll. Cells fromMll KO yolk
sacs or fetal livers produced fewer colonies in myeloid
CFU assays compared to wild-type cells (Ernst et al.,
2004b; Hess et al., 1997; Yagi et al., 1998). Our data are
consistent with this, in that we see reduced numbers of
colonies in Mll KO cultures. We also see this defect in
adult bone marrow progenitors lacking Mll, where the
number of CFUs formed in both myeloid and Pre-B CFU
bone marrow assays are reduced. This suggests that Mll
is necessary for the proper expansion of progenitors in
culture.
In the study presented here, investigation into the status
of fetal liver HSCs shows a severe reduction in the number
of LT-HSCs and ST-HSCs in Mll KO embryos. The stem
cells that remain are able to support limited expansion of
Ter119+ cells in the fetal liver. However, the population
of quiescent HSCs in Mll KO fetal livers is severely re-
duced. When these cells are transplanted into irradiated
recipients, they are unable to compete with WT cells and
contribute to either long- or short-term hematopoiesis,
suggesting a cell-intrinsic defect in the capacity of the
LT-HSCs and the ST-HSCs for self-renewal.r Inc.
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Results of competitive repopulation assays using Mll Flox/+, Mll Flox/, and Mll cKO bone marrow cells. Ly5.2+ bone marrow from two mice of each
genotype was pooled and used for transplantations. The cells were mixed with C57Bl/6J Ly5.1+ bone marrow competitor cells in 1:1 and 10:1 ratios
and injected into lethally irradiated recipients. Error bars show the mean and the SEM. All samples were compared toMllFlox/+ using one-way ANOVA,
with Tukeys multiple comparison test.
(A) Reconstitution at 4 weeks posttransplantation by Mll cKO bone marrow when mixed with wild-type competitors in 1:1 ratio and 10:1 ratios. The
graph shows the percentage of Ly5.2+ cells present in the peripheral blood of recipients. For all samples, n = 5, except Flox/+ 1:1, where n = 4.
(B) Reconstitution at 4 months posttransplantation byMll cKO bone marrow when mixed with wild-type competitors in 1:1 ratio and 10:1 ratios. The
graph shows the percentage of Ly5.2+ cells present in the spleen of recipients. For all samples, n = 5, except Flox/+ 1:1 and cKO 10:1, where n = 4.
(C) Representative flow cytometric plots showing reconstitution levels in the organs of recipients at 4 months. Single-cell suspensions were prepared
from spleen, bone marrow, and thymus, and Ly5.1+ and Ly5.2+ cell populations were analyzed by flow cytometry.It is surprising to see no effect of conditionalMll deletion
on the development of mature lineages in the bone mar-
row of adult mice. A similar scenario has been reported
for other genes known to be important for fetal hematopoi-
esis when deleted in adults (Ichikawa et al., 2004; Mikkola
et al., 2003). This suggests that althoughMll is required for
the proper establishment of hematopoiesis in the embryo
it is not required to maintain hematopoiesis postnatally.
Very high levels of Mll allele recombination are observed
in all major hematopoietic organs in Mll cKO mice, con-
firming that hematopoietic cells do not require Mll for
expansion and differentiation. We cannot completely
discount the possibility that cells that have escaped re-
combination contribute to the stem cell pool, as Vav Cre
is continually expressed throughout the differentiation of
hematopoietic cells (de Boer et al., 2003). This prevents
detection of mature cells derived from unrecombined
cells. However, the high rate of recombination in LSK cells
suggests that the consequences of this are negligible.
In contrast to the phenotype in fetal liver HSCs, the bone
marrow HSC population shows no apparent abnormalities
under homeostatic conditions in the absence ofMll. How-Cellever, these cells give very little reconstitution at both 4
weeks and 4 months posttransplantation when trans-
planted with wild-type competitors into lethally irradiated
recipients. This defect is not due to defective homing of
the cells. These results suggest Mll is critical for the func-
tion of both LT-HSCs and ST-HSCs in these assays (as
defined by Christensen and Weissman, 2001; Spangrude
et al., 1995).
Mll is one of several genes that, although not appearing
to regulate HSCs under homeostatic conditions, are
neededunderconditionsof replicative stress. Thesegenes
include the transcription factors Hoxa9 and Gfi1 and the
cyclin dependent kinase (CDK) inhibitor p21cip1/waf1
(Cheng et al., 2000; Hock et al., 2004; Lawrence et al.,
2005). Mice deficient in these genes have normal or even
elevated levels of HSCs. However, HSCs deficient in
Hoxa9, Gfi1, and p21cip1/waf1 are unable to serially trans-
plant and show self-renewal defects (Cheng et al., 2000;
Hock et al., 2004; Lawrence et al., 2005). In the case of
Gfi1 and p21cip1/waf1, a reduction in the quiescent bone
marrow HSC population was also observed, similar to
that seen in Mll KO fetal livers (Cheng et al., 2000; HockStem Cell 1, 338–345, September 2007 ª2007 Elsevier Inc. 343
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quired tomaintain stemcells in a quiescent state uponpro-
liferative stress (Cheng et al., 2000; Hock et al., 2004). It is
possible thatMllmayalsobe necessary for the response to
replicative stress. This may explain the more severe phe-
notype seen in HSCs from Mll KO fetal livers as opposed
to adult bone marrow, as a higher proportion of HSCs are
cycling in fetal liver in order to facilitate expansionof thedif-
ferent hematopoietic populations during development.
This places the cells under increased replicative stress
(Nygren et al., 2006).
In conclusion, we have shown thatMll, while being dis-
pensable for the production ofmature adult hematopoietic
lineages, plays a critical role in stem cell self-renewal in fe-
tal liver and adult bone marrow. Further analyses of fetal
and adult hematopoiesis in the absence ofMllmay reveal
more specialized roles forMll and also identifyMll targets
responsible for mediating the response to replicative
stress in HSCs.
EXPERIMENTAL PROCEDURES
Western Blotting
Whole-cell lysates for western blotting were prepared with 23 SDS-
DTT sample buffer. Lysates were run on SDS-PAGE gels and
transferred according to standard protocols. After transfer, blots
were incubated with either an anti-MLL N terminus antibody (Clone
N4.4, Upstate) or anti-MLL C terminus antibody (Clone 9-12, Upstate)
to detect both the MLL cleavage fragments (Hsieh et al., 2003). Anti-
Hsp90 polyclonal antibody (Cell Signaling Technology) was used as
the loading control.
Colony-Forming Assays
Single-cell suspensions were prepared from adult bone marrow.
For Pre-B assays, 5.5 3 104 viable nucleated cells were plated into
1.1 ml M3630 methylcellulose media (Stem Cell Technologies) and
CFUs were counted after 7 days. For myeloid assays, 2.73 104 nucle-
ated cells were plated in 1.1 ml M3434media (Stem Cell Technologies)
and CFUs were scored after 10 days.
All graphs and statistical data were produced with GraphPad Prism
4 or Microsoft Excel.
Flow Cytometric Analyses of Fetal Liver and Adult
Hematopoietic Cells
Single-cell suspensions were prepared from E13.5 fetal livers. Cells
were stained with a Lineage antibody cocktail (CD3, CD45R/B220,
Ly6G and Ly-6C, and TER-119). A small number of stained cells
were retained for analysis. Lineage-positive cells were depleted by
magnetic sorting (Miltenyi). Lineage-negative cells were incubated
with anti-Fcg III/II receptor mAb2.4G2 to prevent nonspecific antibody
binding and then incubated with c-kit-APC, Sca1 FITC, CD38 PE,
7AAD (to exclude dead cells), and Streptavidin-PrCP.
To analyze adult hematopoietic cells, single-cell suspensions were
prepared from bone marrow, lymph nodes, thymus, spleens, or pe-
ripheral blood. Cells were incubated with anti-Fcg III/II receptor
mAb2.4G2 and then stained with a combination of the following anti-
bodies: B220 APC, c-kit APC, Gr1 APC, Mac1 FITC, Ly5.2 FITC,
Sca1 PE, CD4 PE, Ly5.1 PE, Lineage antibody cocktail (as for fetal
liver but with the addition of CD11b), CD8a Tricolor, Streptavidin
PrcP, and isotype controls. All antibodies were supplied by eBioscien-
ces, PharMingen, or Caltag. Cells were analyzed with a Dakocytoma-
tion Cyan ADP flow cytometer and Summit 4.2 and 4.3 software
(Dakocytomation).344 Cell Stem Cell 1, 338–345, September 2007 ª2007 ElsevAnalysis of Fetal HSC Cell-Cycle Profile
Single-cell suspensions were made from individual E13.5 fetal livers as
before. After erythrocyte removal, cells were stained with c-kit APC
and Sca1 PE antibodies. Cells were then fixed and permeabilized by
using a BrdU staining kit (BD PharMingen) according to the manufac-
turer’s protocols. The cells were then incubated with Ki67 and isotype
controls (Ki67 staining kit, BD PharMingen) and stained overnight with
7AAD. Cells were analyzed with a Cyan ADP flow cytometer as before.
Reconstitution Experiments
For reconstitution experiments with fetal liver, cells were isolated from
Mll KO and littermate Mll WT E14.5 embryos and frozen in 90% FCS
and 10% DMSO. After genotyping, the cells were thawed, pooled by
genotype, and then stained with c-kit APC and Ter119 PE antibodies.
c-kithiTer119 cells were isolated by magnetic cell sorting (MACS,
Miltenyi) and counted by using trypan blue exclusion to assess viabil-
ity. C57BL/6J Ly5.1 recipients were irradiated with a first dose of 5 Gy
and a second dose of 4 Gy. They were then injected with 43 104 viable
sorted fetal liver cells plus a radioprotective dose of 23 105 C57BL/6J
Ly5.1+ bone marrow cells. Blood was taken from the recipients 4
weeks posttransplantation, and reconstitution levels were assessed
by flow cytometry. After 4 months, the recipients were sacrificed and
the bone marrow, spleen, and thymus were analyzed for the presence
of Ly5.1- and Ly5.2-positive cells by flow cytometry. For reconstitu-
tions with adult bone marrow cells, bone marrow was prepared from
two mice for each genotype. After erythrocyte removal, cells were
pooled and counted for each genotype. For the 10:1 ratio, 23 106 cells
from each genotype were mixed with 2 3 105 Ly5.1+ C57Bl/6J bone
marrow cells and injected into five lethally irradiated C57Bl/6J Ly5.1+
recipients. For the 1:1 ratio, 1 3 106 cells from each genotype were
mixed with 1 3 106 WT competitor cells. Reconstitution was analyzed
as previously described.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures
and five figures and can be found with this article online at http://
www.cellstemcell.com/cgi/content/full/1/3/338/DC1/.
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